1. A phase I study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, for intravenous (IV) administration in patients with advanced solid tumors. (December 2016) Authors: Razak, A.; Gore, L.; Britten, C.D.; Miller, W.H.; Uy, G.L.; Nichols, G.; Middleton, S.; Blotner, S.; Zhi, J.; Jukofsky, L.; Pierceall, W.; Higgins, B.; Chen, L.C. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ketoprofen pharmacokinetics of R‐ and S‐isomers in juvenile loggerhead sea turtles (Caretta caretta) after single intravenous and single‐ and multidose intramuscular administration. Issue 2 (22nd October 2017) Authors: Thompson, K. A.; Papich, M. G.; Higgins, B.; Flanagan, J.; Christiansen, E. F.; Harms, C. A. Journal: Journal of veterinary pharmacology and therapeutics Issue: Volume 41:Issue 2(2018) Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗